Medpace (MEDP) P/E (2016 - 2026)
Medpace (MEDP) P/E from Aug 11, 2016 to Jul 21, 2026. The TTM Medpace (MEDP) P/E is 32.70. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Medpace (MEDP)
| Year | P/E | Change |
|---|---|---|
| 2026 | 32.70 | -8.23% |
| 2025 | 35.63 | +40.32% |
| 2024 | 25.39 | -26.39% |
| 2023 | 34.49 | +12.50% |
| 2022 | 30.66 | -28.70% |
| 2021 | 43.00 | +26.29% |
| 2020 | 34.05 | +13.21% |
| 2019 | 30.08 | +16.87% |
| 2018 | 25.74 | -49.56% |
| 2017 | 51.02 | -46.62% |
| 2016 | 95.59 | N/A |
Comparison Medpace (MEDP) P/E with competitors
Medpace (MEDP) P/E is 32.70.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -96.79% |
| MBAI | CheckCap Ltd | 1.71 | -94.76% |
| FONR | Fonar Corp | 15.48 | -52.67% |
| QGEN | Qiagen NV | 20.03 | -38.75% |
| DGX | Quest Diagnostics Inc | 22.47 | -31.27% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -27.00% |
| IQV | IQVIA Holdings Inc | 25.28 | -22.68% |
| A | Agilent Technologies Inc | 26.96 | -17.56% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -3.58% |
| MTD | Mettler-Toledo International Inc | 32.45 | -0.76% |
| DHR | Danaher Corp | 38.55 | +17.90% |
| IDXX | Idexx Laboratories Inc | 40.58 | +24.08% |
| ILMN | Illumina Inc | 44.12 | +34.92% |
| RVTY | Revvity Inc | 52.68 | +61.10% |
| VCYT | Veracyte Inc | 53.71 | +64.26% |
| ICLR | Icon Plc | 57.45 | +75.69% |
| SHC | Sotera Health Company | 74.08 | +126.56% |
| WAT | Waters Corp | 102.79 | +214.33% |